A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (Q2861803)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients |
scientific article; zbMATH DE number 6224974
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients |
scientific article; zbMATH DE number 6224974 |
Statements
A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (English)
0 references
11 November 2013
0 references
Bayesian statistics
0 references
clinical trial
0 references
dose-escalation study
0 references
dynamic treatment regime
0 references
nonmixture cure model
0 references
0 references
